期刊文献+

多孔羟基磷灰石微球的药物缓释性能 被引量:3

Drug Release Behavior of Porous Hydroxyapatite Microspheres
原文传递
导出
摘要 用锂钙硼(LCB)玻璃在磷酸盐溶液中的原位转化反应制备多孔羟基磷灰石(HA)微球,表征微球的物相组成、孔结构和形貌,以溶菌酶为药物模型研究了药物的缓释性能。结果表明,所制备的HA微球具有较好的孔结构。当溶菌酶溶液的浓度较低时,HA微球将溶菌酶吸附在微球的外表面;当浓度较高时,更多的溶菌酶扩散进入HA微球的微孔中,使缓释效果明显改善。当溶菌酶溶液的初始浓度为1.0 mg/ml时,载药HA微球的释药周期可达800 h以上。 Porous hydroxyapatite(HA) microspheres were prepared by a situ Li-Ca-B glass conversion process.The phase composition,pore structure and morphology were characterized by XRD,SEM and BET.The results show that the resultant microspheres possess good internal porous structure.The release behavior of lysozyme as a model drug was investigated in the present work.The results show that lysozyme molecules mainly are absorbed on the external surface of the porous HA when concentration of lysozyme is low.A large amount of lysozyme is loaded in the pores of the microspheres when high concentration of lysozyme is used,which effectively prolonged the drug release.The loading behavior was successfully observed in the 1.0 mg/ml lysozyme solution and the drug can still be released after 800 hours.
出处 《材料研究学报》 EI CAS CSCD 北大核心 2011年第4期439-443,共5页 Chinese Journal of Materials Research
基金 上海市科委"创新行动计划"基础研究重点08JC1419200 同济大学青年优秀人才培养行动计划资助项目~~
关键词 无机非金属材料 羟基磷灰石 多孔微球 溶菌酶 药物缓释载体 inorganic non-metallic materials hydroxyapatite porous microsphere lysozyme drug controlled-release carrier
  • 相关文献

参考文献13

  • 1张纲,谭颖徽.多肽、蛋白质药物的载体相关研究[J].口腔颌面外科杂志,2009,19(3):220-223. 被引量:4
  • 2M.Isobe, Y.Yamazaki, M.Mori, K.Ishihara, N.Nakabayashi, T.Amagasa, The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat, Journal of Oral and Maxillofacial Surgery, 57(6), 695(1999).
  • 3J.B.Oldham, L.Lu, X.Zhu, B.D.Porter, T.E.Hefferan, D.R.Larson, Biological activity of rhBMP-2 released from PLGA microspheres, Journal of Biomechanical Engineering, 122(3), 289(2000).
  • 4杨为中,周大利,尹光福,尹绍雅,郑昌琼.磷酸钙/BMP复合生物活性骨水泥水化性能及诱导成骨特性研究[J].无机材料学报,2005,20(5):1174-1180. 被引量:10
  • 5王海亭,陈磊,金雪玲,朱海涛.羟基磷灰石(HAP)材料在生物材料中的研究与开发[J].山东陶瓷,2002,25(2):3-8. 被引量:11
  • 6M.P.Ferraz, F.J.Monteiro, C.M.Manuel, Hydroxyapatite nanoparticles: a review of preparation methodologies, Journal of Applied Biomaterials & Biomechanics, 2, 74(2004).
  • 7L.L Hench, Biomaterials, Science, 208(23), 826(1980).
  • 8W.H¨oland, V.Rheinberger, E.Apel, C.Van Thoen, M.H¨oland, A.Dommann, M.Obrecht, C.Mauth, U.Graf-Hausner, Clinical applications of glass-ceramics in dentistry, Journal of Materials Science: Materials in Medicine, 17(11), 1037(2006).
  • 9B.Palazzo, M.C.Sidoti, N.Roveri, A.Tampieri, M.Sandri, L.Bertolazzi, F.Galbusera, G.Dubini, P.Vena, R.Contro, Controlled drug delivery from porous hydroxyapatite grafts: An experimental and theoretical approach, Materials Science and Engineering C, 25, 207(2005).
  • 10A.M.Rauschmanna, A.T.Wichelhausb, V.Stirnal, E.Dingeldein, L.Zichner, R.Schettler, V.Alt, Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections, Biomaterials, 26(15), 2677(2005).

二级参考文献81

共引文献29

同被引文献118

  • 1张启焕,闫玉华,陈晓明,江昕.多孔β-TCP陶瓷药物载体的制备与体外释药速率的研究[J].山东陶瓷,2004,27(3):3-4. 被引量:5
  • 2Li Z,Guan J.Thermosensitive hydrogels for drug delivery[J].Ex-pert Opin Drug Deliv,2011,8﹙8﹚:991-1007.
  • 3Vallet-RegíM,Balas F,Arcos D.Mesopourous Materials for DrugDelivery[J].Angew Chem IntEd Engl,2007,46﹙40﹚:7548-7558.
  • 4Zilberman M,Elsner JJ.Antibiotic-eluting medical devices forvarious applications[J].J Control Release,2008,130﹙3﹚:202-215.
  • 5Mourino V,Boccaccini AR.Bone tissue engineering therapeutics:controlled drug delivery in three-dimensional scaffolds[J].J R SocInterface,2010,7﹙43﹚:209-227.
  • 6Dorozhin SV.Bioceramics of calcium orthoposphates[J].Bioma-terials,2010,31﹙7﹚:1465-1485.
  • 7Donadel K,Felisberto MD,Laranjeira MC.Preparation and char-acterization of hydroxyapatite-coated iron oxide particles byspray-drying technique[J].An Acad Bras Cienc,2009,81﹙2﹚:179-186.
  • 8Pham HH,Luo P,Genin F,et al.Synthesis and charanterization ofhydroxyapatite-ciprofloxacin delivery systems by precipitationand spray drying technique[J].AAPS PharmSciTech,2002,3﹙1﹚:1-9.
  • 9Liu H,Zhang L,Shi P,et al.Hydroxyapatite polyurethane scaffoldincorporated with drug-loaded ethyl cellulose microspheres forbone regeneration[J].J Biomed Mater Res B Appl Biomater,2010,95﹙1﹚:36-46.
  • 10Ravelingien M,Mullen S,Luyten J,et al.Vancomycin release frompoly﹙D,L-lactic acid﹚spary-coated hydroxyapatite fibers[J].Eur JPharm Biopharm,2010,76﹙3﹚:366-370.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部